Dr. Rodney Ho is the TLC-ART principal investigator and program director, professor and presidential entrepreneurial fellow of the University of Washington. Read more.
Kristina Adams Waldorf, MD is the Clinical Lead for the TLC-ART Program. Read more.
Dr. Zachary Stephen joined Dr. Ho’s lab as a Research Scientist in June 2021. He received his PhD from UW in 2016 and carried out his postdoctoral research in the Dept. of Materials Science and Engineering. Read More.
Dr. Simone Perazzolo is a Sr Research Associate Scientist for physiologically-based mathematical/computational modeling (e.g. PBPK). He’s currently developing the PK understanding of drug-combo nanoparticles for long-acting therapies to be used in the treatment of HIV, HBV, cancer, and SARS-CoV2. Read More.
Dr. Masakatsu Eguchi received his PhD degree in Organic Chemistry from Brigham Young Univ. in 1990. He joined the lab as a research scientist in 2021. Dr. Eguchi has been actively involved in drug discovery efforts for 27 years, resulting in the development of 2 new investigational drugs. Read More.
Dr. Qingxin Mu joined Dr. Ho’s lab as a Research Scientist in June, 2017. He received his PhD degree in Shandong University in China, 2010. His current work focuses on formulation, characterization and evaluation of long-acting lipid-based drug combination nanoparticles for anticancer and anti-HIV drug delivery. Read More.
Rachele Delle Fratte, MS is a Research Scientist II in Dr. Ho’s lab. She joined the team in November 2022, following the completion of her master’s degree in London, UK. She previously worked as a critical care nurse in the Medical ICU at Johns Hopkins Hospital in Baltimore, MD. Read More.
Xiaolin (Alin) Xu, BS graduated from the Univ. of Kentucky in May 2020 and then joined Dr. Ho’s lab as a master’s student. She is doing her research on breast cancer drug therapy using Gemcitabine and Paclitaxel nanoparticles. Read More.
Luqi Duan, Ph.D. finished medical school at Zhengzhou University, China, in 2010. She obtained a Master of Clinical Medicine from the same institution in 2012. During her master’s program, as a Visiting Scholar, she studied at the University of Gothenburg, Sweden, She focused on the brain’s immune response to hypoxia-ischemia in a mouse model of preterm brain injury. In 2020, Dr. Duan earned her Ph.D. in Toxicology from the University of Kansas Medical Center (KUMC), USA. Her expertise encompasses toxicology, pharmacology, immunology, and molecular cell biology. In 2023, she joined Dr. Ho’s lab.
Keegan Klein, B.S. works in Dr. Ho’s lab as a Research Scientist I. After earning his bachelor’s degree in Los Angeles, California, he joined the team in March 2024. In the past, he was employed at BioLife Solutions in Bothell, Washington, as an aseptic technician. His undergraduate studies had already sparked his interest in pharmaceutical research, so joining Dr. Ho’s lab felt like the next natural step. As a member of Dr. Ho’s lab, he is using his industrial knowledge to support the significant research being conducted here while also strengthening his research foundation and learning new research techniques.
Shreshtha Dash, Ph.D., is a Research Scientist II in Dr. Ho’s lab. She earned her Ph.D. in Biomedical Sciences from Creighton University, Omaha, in 2024. Before that, she practiced dentistry in India before moving to the United States to pursue a Master’s in Pharmaceutical Sciences, which she earned in 2020. She has extensive experience in analytical method development for small molecules, as well as the formulation and characterization of nanoparticles for localized drug delivery. Her expertise spans liquid chromatography, mass spectrometry, and bioanalysis, contributing to advancements in targeted drug delivery and pharmaceutical development.
Leila Kirkpatrick, MPH. joined TLC-ART in January 2025. She holds an MPH from Tufts University in Global Health, and she has worked in the public, private, and non-profit sectors, including 2.5 years with the UW Department of Pharmaceutics. Leila handles fiscal and programmatic needs for the TLC-ART program.
Dr. Matthew Hartman is the Project Administrator for TLC-ART. He joined the lab in July of 2019 after finishing a postdoc in Political Science at the University of Notre Dame. Read More
Aaron A Haley is an Assistant Project Administrator for TLC-ART
Jeff Munson, PhD is a Data Scientist and Research Associate Professor of Psychiatry and Behavioral Sciences reporting to Dr K Waldorf.